Table 4.
In vivo model (route of infection) | Drugs dosed at: | Mean ED50 value (mg/kg/dose) | ||
---|---|---|---|---|
Ceftiofur (n) | Clinafloxacin (n) | Enrofloxacin (n) | ||
Bovine M. haemolytica (IP) | 1, 24, and 48 h post-challenge | 0.28 (5) | 0.019 (5) | 0.29 (5) |
1 and 3 h post-challenge | 0.22 (2) | 0.008 (2) | na | |
Bovine P. multocida (IN) | 18 h post-challenge | 1.05 (2) | 0. 55 (2) | na |
Bovine P. multocida (IP) | 1 and 3 h post-challenge | 0.11 (3) | 0.08 (3) | 0.26 (3) |
Swine A. pleuropneumoniae (IP) | 1, 24, and 48 h post-challenge | 8.2 (3) | 0.7 (3) | 1.8 (3) |
IP, intraperitoneal; IN, intranasal; n, number of tests; na, not available.